Viewing Study NCT02677805


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2026-02-21 @ 12:17 PM
Study NCT ID: NCT02677805
Status: COMPLETED
Last Update Posted: 2025-03-19
First Post: 2016-02-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
Sponsor: Croma-Pharma GmbH
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-03-30
Start Date Type: ACTUAL
Primary Completion Date: 2016-09-15
Primary Completion Date Type: ACTUAL
Completion Date: 2017-11-03
Completion Date Type: ACTUAL
First Submit Date: 2016-02-04
First Submit QC Date: None
Study First Post Date: 2016-02-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-12-17
Results First Submit QC Date: None
Results First Post Date: 2025-03-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2020-02-07
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2025-03-11
Last Update Post Date: 2025-03-19
Last Update Post Date Type: ACTUAL